Noggin maintains pluripotency of human embryonic stem cells grown on Matrigel

Cell Prolif. 2009 Aug;42(4):425-33. doi: 10.1111/j.1365-2184.2009.00616.x. Epub 2009 Jun 2.

Abstract

Objective: Spontaneous differentiation of human embryonic stem cell (hESC) cultures is a major concern in stem cell research. Physical removal of differentiated areas in a stem cell colony is the current approach used to keep the cultures in a pluripotent state for a prolonged period of time. All hESCs available for research require unidentified soluble factors secreted from feeder layers to maintain the undifferentiated state and pluripotency. Under experimental conditions, stem cells are grown on various matrices, the most commonly used being Matrigel.

Materials and methods: We propose an alternative method to prevent spontaneous differentiation of hESCs grown on Matrigel that uses low amounts of recombinant noggin. We make use of the porosity of Matrigel to serve as a matrix that traps noggin and gradually releases it into the culture to antagonize bone morphogenetic proteins (BMP). BMPs are known to initiate differentiation of hESCs and are either present in the conditioned medium or are secreted by hESCs themselves.

Results: hESCs grown on Matrigel supplemented with noggin in conditioned medium from feeder layers (irradiated mouse embryonic fibroblasts) retained both normal karyotype and markers of hESC pluripotency for 14 days. In addition, these cultures were found to have increased cell proliferation of stem cells as compared to hESCs grown on Matrigel alone.

Conclusion: Noggin can be utilized for short term prevention of spontaneous differentiation of stem cells grown on Matrigel.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Morphogenetic Proteins / antagonists & inhibitors
  • Carrier Proteins / administration & dosage
  • Carrier Proteins / genetics
  • Carrier Proteins / pharmacology*
  • Cell Culture Techniques / methods*
  • Cell Differentiation / drug effects
  • Cell Line
  • Cell Proliferation / drug effects
  • Chorionic Gonadotropin, beta Subunit, Human / metabolism
  • Collagen / pharmacology*
  • Culture Media, Conditioned / pharmacology
  • Delayed-Action Preparations / pharmacology
  • Drug Combinations
  • Embryonic Stem Cells / cytology*
  • Embryonic Stem Cells / drug effects
  • Embryonic Stem Cells / metabolism
  • Gene Expression
  • Humans
  • Immunohistochemistry
  • Laminin / pharmacology*
  • Octamer Transcription Factor-3 / genetics
  • Octamer Transcription Factor-3 / metabolism
  • Pluripotent Stem Cells / cytology*
  • Pluripotent Stem Cells / drug effects*
  • Pluripotent Stem Cells / metabolism
  • Proteoglycans / pharmacology*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / genetics
  • Recombinant Proteins / pharmacology
  • Time Factors

Substances

  • Bone Morphogenetic Proteins
  • Carrier Proteins
  • Chorionic Gonadotropin, beta Subunit, Human
  • Culture Media, Conditioned
  • Delayed-Action Preparations
  • Drug Combinations
  • Laminin
  • Octamer Transcription Factor-3
  • POU5F1 protein, human
  • Proteoglycans
  • Recombinant Proteins
  • matrigel
  • noggin protein
  • Collagen